Search

everythinglearnresearchcommunity

for

Search:↓

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Minoxidil and finasteride are the only FDA-approved treatments for hair loss caused by genetic and hormonal factors, but their effectiveness is often doubted, indicating a need for new treatments.

Higher IL-17A levels indicate more severe alopecia areata.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Superficial cryotherapy is effective and safe for treating alopecia areata, with better results when used early and frequently.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

Turmeric may have benefits for skin health, but more research is needed to confirm its effectiveness.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

A boy with alopecia regrew hair using a vitamin D cream after other treatments failed.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Lupus can look like hair loss from alopecia areata but needs different treatment.

Stopping the medication infliximab and starting new treatments helped a woman's hair grow back and improved her scalp condition.

A woman with lupus experienced skin death due to a blood clotting disorder after stopping a blood thinner, which healed with treatment.

Platelet Rich Plasma (PRP) treatment is safe and effective for hair growth in people with androgenic alopecia, and can also help treat bacterial infections.

Cleanroom workers in a battery factory have worse skin and eye conditions due to the very dry environment.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

The study found that expanded skin regenerates similarly to normal skin, with 77 genes playing a role in the process.

Two plywood factory workers developed contact dermatitis from phenol-formaldehyde resin, a known allergen.

Cyclosporin A promotes hair growth in mice and increases a protein linked to hair growth, but it may not work the same way in humans.

Erdr1 could be a new marker for diagnosing hair loss.

Some skin medications are safe during pregnancy and breastfeeding, but others can harm the baby and should be avoided.

Rhodococcus equi causes severe pneumonia in young foals, and effective vaccines are needed due to foals' weak immune responses.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.